Gwen Nichols, MD
Chief Medical Officer, LLS
Information about the COVID-19 pandemic changes daily. And, as the virus continues to spread, especially with the Delta variant, vaccine effectiveness among immuno-compromised people remains an urgent issue. LLS is leading several critical collaborative research efforts to understand COVID-19 vaccine effectiveness for blood cancer patients.
Join us as we talk with leading physician-researchers about blood cancer patients’ responses to the vaccines, as well as emerging knowledge about vaccine boosters. We will also share early results from LLS-funded research, including data from the LLS National Patient Registry’s special COVID project.
LLS Research Now is a monthly videoconference series spotlighting LLS research and funded researchers. We'll share how the LLS mission is moving forward, making a difference and helping patients despite COVID-19 thanks to LLS supporters.
1:00 - 2:00 pm ET
Event held via Zoom and link will be provided after registering.